In fact, IFN-α has been considered as the driving factor in several human autoimmune diseases such as Systemic Lupus Erythematosus (SLE) [3], myositis, Sjogren's syndrome and the initial phase of psoriasis [1]. Here, IFNA2 is linked to systemic lupus erythematosus.